Global Processing

Mylan acquires eastern European Merck KGaA units

June 2, 2008
The Associated Press is reporting that generic and specialty pharmaceutical company Mylan Inc. said recently it has acquired the central eastern European generics businesses of German drug maker Merck KGaA, as part of an agreement signed last year.

Mylan exercised its option to acquire the businesses under its original agreement from October 2007, in which Mylan acquired Merck KGaA''s generics business in Western Europe, Asia-Pacific, Africa and North America.

Mylan said the latest acquisition does not require any additional consideration to Merck and includes operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.

Mylan Vice Chairman and Chief Executive Robert J. Coury said the acquisition gives the company access to areas with significant growth opportunities for generics.

Darmstadt-based Merck has been separate from the U.S.-based Merck & Co. since the end of World War I.